WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Screenwriter Chen Yu amazed by young filmmakersAI data training supported by domestic chips, supercomputersMan arrested in fatal shooting of Chicago police officer who was heading home from workWith PSG crowned French champion, the race for remaining Champions League spots rumbles onDeath toll from heavy rains in southern Brazil jumps to 29, with 60 more still misingShanghai citizens average 12 books per yearAI data training supported by domestic chips, supercomputersBurg Chinese Chorus celebrates 10th anniversary with concert in GermanyImperial Chinese wine jar stolen from Belgian museumChina flays overseas talk about 'overcapacity'
3.0005s , 6514.9140625 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Stellar Station news portal